Trial Search Results

Stress, Diurnal Cortisol, and Breast Cancer Survival

The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institute on Aging (NIA)

Stanford Investigator(s):


  • Drug: Sandostatin


Inclusion Criteria:

   1. Diagnosis of recurrent or metastatic breast cancer.

   2. Karnofsky of 70% or greater.

   3. Proficient enough in English to be able to take questionnaires and participate in the
   required tasks.

   4. Living within the Greater Bay Area.

   5. Age 35 or older .

Exclusion Criteria:

   1. Positive supraclavicular lymph nodes as the only metastatic lesion at the time of
   initial diagnosis.

   2. Active cancers within the past 10 years other than breast cancer, basal cell or
   squamous cell carcinomas of the skin, or in situ cancer of the cervix.

   3. Any other serious medical condition that will effect short term survival

   4. History of major psychiatric illness for which patient was hospitalized or medicated,
   with the exception of depression or anxiety

   5. A diagnosis of diabetes.

Ages Eligible for Study

35 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Bita Nouriani